Abstract
The purpose of the work– to analyze the data of modern literature concerning expediencyof using sodium- dependent glucose cotransporter type 2 inhibitors in the early stages ofacute myocardial infarction to improve the prognosis and reduce mortality.Conclusions. The analysis of literature data shows the growing evidence of iNZKTG2effectiveness as the newest generation of cardiorenal protectors. The potential effects ofiNZCTH2 may be particularly beneficial for patients with acute myocardial infarction.Proving the effectiveness of iNZCTH2 in acute myocardial infarction may become thebasis for revising the standards of treatment of this common acute cardiovascular disease,which leads to significant complications and mortality.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
